Suppr超能文献

手部和腕部局部注射皮质类固醇对糖尿病患者血糖的影响。

Effect of local corticosteroid injection of the hand and wrist on blood glucose in patients with diabetes mellitus.

作者信息

Catalano Louis W, Glickel Steven Z, Barron O Alton, Harrison Richard, Marshall Astrid, Purcelli-Lafer Marissa

机构信息

C.V. Starr Hand Surgery Center, New York, New York 10019, USA.

出版信息

Orthopedics. 2012 Dec;35(12):e1754-8. doi: 10.3928/01477447-20121120-20.

Abstract

Locally administered corticosteroids are a common therapy in many hand and wrist disorders. Corticosteroids pose a theoretical risk to patients with diabetes mellitus by potentially raising blood glucose to hyperglycemic levels. Although oral corticosteroids are known to have an effect on blood glucose control, limited data exist on extra-articular administration. The purpose of this study was to examine the systemic impact of extra-articularly administered corticosteroids in the hand and wrist on serum glucose concentration in patients with diabetes mellitus.Twenty-three patients with diabetes mellitus received a 1-mL triamcinolone acetonide injection for de Quervain's tenosynovitis, trigger finger, flexor carpi ulnaris tendonitis, or carpal tunnel syndrome. Patients recorded their daily morning blood glucose levels for 1 week before injection and for 4 weeks after injection. Average blood glucose levels increased slightly from baseline after injection, reaching statistical significance 1, 5, and 6 days after injection, but were not clinically significant (average increase, 14.2, 9.7, and 32.7 mg/dL, respectively). Isolated increases more than 2 times the standard deviation of preinjection values occurred at least once in the majority of patients. The frequency of hyperglycemic episodes increased after injection, but the proportions of patients with at least 1 hyperglycemic episode before and after injection were not significantly different.These results suggest that local corticosteroid injections are a clinically safe treatment option for inflammatory processes of the hand and wrist in patients with diabetes mellitus. On average, patients experienced slight increases in blood glucose after receiving an injection. Most experienced isolated increases substantially beyond baseline and isolated hyperglycemic effects, but these did not pose an apparent clinical risk.

摘要

局部注射皮质类固醇是许多手部和腕部疾病的常见治疗方法。皮质类固醇可能会使血糖升高至高血糖水平,因此理论上对糖尿病患者存在风险。虽然已知口服皮质类固醇会影响血糖控制,但关于关节外给药的数据有限。本研究的目的是探讨手部和腕部关节外注射皮质类固醇对糖尿病患者血清葡萄糖浓度的全身影响。23例糖尿病患者因桡骨茎突狭窄性腱鞘炎、扳机指、尺侧腕屈肌腱炎或腕管综合征接受了1毫升曲安奈德注射。患者记录了注射前1周和注射后4周每天早晨的血糖水平。注射后平均血糖水平较基线略有升高,在注射后第1、5和6天达到统计学显著性,但在临床上无显著意义(平均升高分别为14.2、9.7和32.7mg/dL)。大多数患者至少有一次单独升高超过注射前值标准差的两倍。注射后高血糖发作的频率增加,但注射前后至少有一次高血糖发作的患者比例无显著差异。这些结果表明,局部注射皮质类固醇对于糖尿病患者手部和腕部的炎症过程是一种临床安全的治疗选择。平均而言,患者在接受注射后血糖略有升高。大多数患者出现单独升高且大幅超过基线以及单独的高血糖效应,但这些并未构成明显的临床风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验